Alprazolam and Eylea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alprazolam (alprazolam) and Eylea (aflibercept). Common drug interactions include death among females and blindness among males.

The phase IV clinical study analyzes what interactions people have when they take Alprazolam and Eylea. It is created by eHealthMe based on reports of 84 people who take the same drugs from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Eylea?

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.

On Jul, 14, 2026

84 people who take Alprazolam and Eylea together, and have interactions are studied.

What are the common drug interactions of Alprazolam and Eylea, by gender? *:

female:

Death
Visual acuity reduced (reduced clearness of vision)
Eye pain
Visual impairment
Vision blurred
Abdominal pain upper
Diarrhoea
Eye inflammation
Fatigue (feeling of tiredness)
Retinal haemorrhage (bleeding from retina)

male:

Blindness
Eye disorder
Eye pain
Vision blurred
Visual impairment
Chest pain
Coronary artery thrombosis (clot formation in coronary artery)
Eye discharge
Headache (pain in head)
Rhinorrhoea (watery mucus discharge from the nose)

What are the common drug interactions of Alprazolam and Eylea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Death
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)

60+:

Visual impairment
Visual acuity reduced (reduced clearness of vision)
Alanine aminotransferase increased
Anterior chamber inflammation
Blindness
Blindness transient (sudden loss of vision)
Blood cholesterol increased
Blood creatine phosphokinase increased
Blood pressure increased
Breast cancer

What are the existing conditions these people have? *

Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 23 people, 27.38%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 8 people, 9.52%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 7 people, 8.33%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 6 people, 7.14%
Age-Related Macular Degeneration: 6 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and Eylea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously